Single Day CBT-Based Workshops for Mothers with Postpartum Depression
In this randomized controlled trial, a CBT-based workshop for women with PPD led to clinically meaningful reductions in depression and anxiety.
Recruiting for Research Study: Pregnenolone Neurosteroid for Menopausal Depression
As of October 2023, the Neurosteroid Intervention for Menopausal and Perimenopausal Depression is no longer recruiting participants. Over the last few years we have heard a great deal about neurosteroids, also known as neuroactive steroids. This class of compounds are steroid hormones produced in the brain and endocrine tissues which can modulate neurotransmission. Animal studies have demonstrated that neurosteroids have a broad range of activities, including antidepressant, anxiolytic, sedative, analgesic, anticonvulsant, [...]
Weekly Roundup for MAY 5, 2023: Recent Publications in Women’s Mental Health
Every week we review the most recent publications in women’s mental health.
On Postpartum Psychosis Awareness Day: Educating Mothers, Families, and Health Care Providers
Postpartum psychosis is the most severe form of postpartum psychiatric illness. What are the signs and symptoms?
Transcranial magnetic stimulation during pregnancy: An alternative to antidepressant treatment?
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on transcranial magnetic stimulation during pregnancy with Ob.Gyn News on May 4th.
Zuranolone Improves Anxiety Symptoms and Insomnia in Women with Postpartum Depression
In women with postpartum depression, zuranolone was associated with concurrent improvements in depression, anxiety symptoms, and insomnia beginning at day 3.